- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Alembic Pharma ropes in G Krishnan as CFO

Vadodara: Alembic Pharma has appointed G Krishnan as the Chief Financial Officer (CFO) and Key Managerial Personnel of the Company.
A seasoned finance leader, Krishnan is a qualified CA, CS and CMA, with over 22 years of diverse experience spanning pharmaceuticals, life sciences, telecom and social sector organizations.
Prior to joining Alembic, he was working with Syngene International Limited since May 2020, as Vice President and Chief Financial Officer of Syngene Scientific Solutions Limited, where he has played a pivotal role in driving strategy, business finance, mergers & acquisitions, governance and risk management. Previously, he has held key leadership roles at Vodafone and Tata Trusts. He brings expertise in business finance, mergers & acquisitions, implementation of scalable systems, governance frameworks and managing diverse finance teams.
His appointment comes as R. K. Baheti, Director – Finance and CFO has relinquished the position of CFO. However, Baheti will continue to serve as an Executive Director of the Company, as per the terms of his appointment.
Read also: Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome
In May, Viraj Save, Executive Vice President - Sales and Marketing resigned from his position at Alembic Pharma.
Read also: Alembic Pharma Viraj Save resigned as Executive Vice President - Sales and Marketing
Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. It is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
Read also: Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751